Promoting good clinical laboratory practices and laboratory accreditation to support clinical trials in Sub-Saharan Africa

American Journal of Tropical Medicine and Hygiene

Volumn 86, Issue 4, 2012, Pages 573-579

  Guindo, Merepen A ^a   Shott, Joseph P ^b   Saye, Renion ^c   Diakité, Moussa L ^a   Sanogo, Sintry ^a   Dembele, Moussa B ^a   Keita, Sekouba ^a   Nagel, Mary C ^d   Ellis, Ruth D ^b   Aebig, Joan A ^b   Diallo, Dapa A ^a   Doumbo, Ogobara K ^a  

^a UNIVERSITY OF BAMAKO   (Mali)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^c USAID Mali   (Mali)

^d Ministry of Health   (Haïti)

Author keywords

[No Author keywords available]

Indexed keywords

MALARIA VACCINE;

ACCREDITATION; ARTICLE; CLIMATE CHANGE; CLINICAL LABORATORY; GOOD LABORATORY PRACTICE; IMMUNOGENICITY; MALI; MEDICAL RESEARCH; SAFETY;

ACCREDITATION; AFRICA SOUTH OF THE SAHARA; BIOMEDICAL RESEARCH; CLINICAL LABORATORY TECHNIQUES; CLINICAL TRIALS AS TOPIC; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; LABORATORIES; MALI; REPRODUCIBILITY OF RESULTS; TOTAL QUALITY MANAGEMENT;

EID: 84860511940     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.2012.11-0691     Document Type: Article

References (15)

1. Dicko A, Sagara I, Diemert D, Sogoba M, Niambele MB, Dao A, Dolo G, Yalcouye D, Diallo DA, Saul A, Miller LH, Toure YT, Klion AD, Doumbo OK, 2007. Year-to-year variation in the age-specific incidence of clinical malaria in two potential vaccine testing sites in Mali with different levels of malaria transmission intensity. Am J Trop Med Hyg 77: 1028-1033. (Pubitemid 351837787)
2. Dicko A, Klion AD, Théra MA, Sagara I, Yalcouyé D, Niambele MB, Sogoba M, Dolo G, Dao A, Diallo DA, Doumbo OK, Miller LH, 2004. The etiology of severe anemia in a village and a periurban area in Mali. Blood 104: 1198-200. (Pubitemid 39038043)
3. Dicko A, Sagara I, Ellis RD, Miura K, Guindo O, Kamata B, Sogoba M, Niambelé MB, Sissoko M, Baby M, Dolo A, Mullen GE, Fay MP, Pierce M, Diallo DA, Saul A, Miller LH, Doumbo OK, 2008. Phase 1 study of a combination AMA1 blood stage malaria vaccine in Malian children. PLoS One 3: e1563.
4. Sagara I, Ellis RD, Dicko AA, Niambelé MB, Kamata B, Guindo O, Sissoko MS, Fay MP, Guindo MA, Kante O, Saye R, Miura K, Long C, Mullen GE, Pierce M, Martin LB, Rausch K, Dolo A, Miller LH, Doumbo OK, 2009. A randomized and controlled Phase 1 study of the safety and immunogenicity of the AMA1-C1/Alhydrogel + CPG 7909 vaccine for Plasmodium falciparum malaria in semi-immune Malian adults. Vaccine 27: 7292-7298.
5. Coulibaly YI, Dembele B, Diallo AA, Lipner EM, Doumbia SS, Coulibaly SY, Konate S, Diallo DA, Yalcouye D, Kubofcik J, Doumbo OK, Traore AK, Keita AD, Fay MP, Traore SF, Nutman TB, Klion AD, 2009. A randomized trial of doxycycline for Mansonella perstans infection. N Engl J Med 361: 1448-1458.
6. Sagara I, Dicko A, Ellis RD, Fay MP, Diawara SI, Assadou MH, Sissoko MS, Kone M, Diallo AI, Saye R, Saye R, Guindo MA, Kante O, Niambelé MB, Miura K, Mullen GE, Pierce M, Martin LB, Dolo A, Doumbo OK, Saul A, 2009. A randomized controlled phase 2 trial of the blood stage AMA1-C1/Alhydrogel malaria vaccine in children in Mali. Vaccine 27: 3090-3098.
7. Dembele B, Coulibaly YI, Dolo H, Konate S, Coulibaly SY, Sango D, Soumaoro L, Coulibaly ME, Doumbia SS, Diallo AA, Traore SF, Diaman Keita A, Fay MP, Nutman TB, Klion AD, 2010. Use of high-dose, twice-yearly albendazole and ivermectin to suppress Wuchereria bancrofti microfilarial levels. Clin Infect Dis 51: 1229-1235.
8. Ellis RD, Dicko A, Sagara I, Kamate B, Guindo O, NiambeléMB, Sogoba M, Doumbo O, 2008. Short report: elevated levels of alanine aminotransferase and hepatitis A in the context of a pediatric malaria vaccine trial in a village in Mali. Am J Trop Med Hyg 79: 980-982.
9. Petti CA, Polage CR, Quinn TC, Ronald AR, Sande MA, 2006. Laboratory medicine in Africa: a barrier to effective health care. Clin Infect Dis 42: 377-382. (Pubitemid 43122314)
10. CLSI, 2000. How to Define and Determine Reference Intervals in the Clinical Laboratory: Approved Guideline. Second edition. Wayne, PA: National Committee for Clinical Laboratory Standards. C28-A2, Vol.20 No 13. 2ed.
11. Eller LA, Eller MA, Ouma B, Kataaha P, Tumusiime R, Wandege J, Sanga R, Sateren WB, Wabwire-Mangen F, Kibuuka H, Robb ML, Michael NL, de Souza MS, 2008. Reference intervals in healthy adult Ugandan blood donors and their impact on conducting international vaccine trials. PLoS One 3: e3919.
12. Ohrt C, Obare P, Nanakorn A, Adhiambo C, Awuondo K, O'Meara WP, Remich S, Martin K, Cook E, Chretien JP, Lucas C, Osoga J, McEvoy P, Owaga ML, Odera JS, Ogutu B, 2007. Establishing a malaria diagnostics centre of excellence in Kisumu, Kenya. Malar J 6: 79.
13. Ohrt C, O'Meara WP, Remich S, McEvoy P, Ogutu B, Mtalib R, Odera JS, 2008. Pilot assessment of the sensitivity of the malaria thin film. Malar J 7: 22.
14. Malkin EM, Diemert DJ, McArthur JH, Perreault JR, Miles AP, Giersing BK, Mullen GE, Orcutt A, Muratova O, Awkal M, Zhou H, Wang J, Stowers A, Long CA, Mahanty S, Miller LH, Saul A, Durbin AP, 2005. Phase 1 clinical trial of apical membrane antigen 1: an asexual blood-stage vaccine for Plasmodium falciparum malaria. Infect Immun 6: 3677-3685. (Pubitemid 40745912)
15. Ellis RD, Fay MP, Sagara I, Dicko A, Miura K, Guindo MA, Guindo A, Sissoko MS, Doumbo OK, Diallo D, 2011. Anemia in a phase 2 study of a blood stage falciparum malaria vaccine. Malar J 10: 13.